Home
Conditions
Immunotherapy

Clinical trial condition

Immunotherapy

Explore clinical trials studying Immunotherapy. Study availability and eligibility vary by location and protocol.

216 public trials 103 recruiting studies

Refine in advanced search Browse all conditions

Immunotherapy trial results

Recruiting

Plasma and Tissue SAA1 Levels in Cancer Patients to Predict Hyperprogression of Immunotherapy

NCT06276088

Conditions: Biomarker, Hyperprogression, Immunotherapy
Locations: Nanfang hospital, Southern medical university Guangzhou, Guangdong, China

Fujian Provinical Hospital Fuzhou, China

Huizhou Central People's Hospital Huizhou, China

Jieyang people's hospital Jieyang, China

View Trial Details

Recruiting

Precision Therapy for Solid Tumors: Synergistic CDK4/6 Inhibition and Anti-VEGF Targeting LncRNA

NCT06307249

Conditions: Adnexal Diseases, Breast Cancer, Breast Diseases, +43 more
Locations: Haykel Hospital Tripoli, North Lebanon, Lebanon

Lebanese University Tripoli, North Lebanon, Lebanon

View Trial Details

Recruiting

Neoadjuvant Camrelizumab Combined With Chemotherapy for Resectable Stage IIIA-IIIB NSCLC

NCT06241807

Conditions: Biomarkers / Blood, Bronchial Neoplasms, Carcinoma, Bronchogenic, +11 more
Locations: Shandong Cancer Hospital and Institute Jinan, Shandong, China

View Trial Details

Recruiting

The Effect of Chronic Stress on Efficacy of ICIs in Esophageal Cancer Patients (STRESS-ESCA Study)

NCT05967910

Conditions: Digestive System Diseases, Digestive System Neoplasms, Esophageal Cancer, +8 more
Locations: Department of Oncology, The Second Xiangya Hospital, Central South University Changsha, Hunan, China

View Trial Details

Recruiting

Stereotactic Radiotherapy Combined With Adebrelimab and TCb (Nab-paclitaxel + Carboplatin) in Neoadjuvant Treatment of TNBC

NCT06165900

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +6 more
Locations: Shengjing Hospital of China Medical University Shenyang, Liaoning, China

View Trial Details

Recruiting

Adjuvant Chemotherapy Combined With Camrelizumab for ⅡA -ⅢA NSCLC Patients

NCT05825443

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations: Nanfang Hospital, Southern Medical University Guandong, Guangdong, China

View Trial Details

Recruiting

Camrelizumab Combined With Neoadjuvant Chemotherapy After Stent Placement for Left-Sided Obstructive Colonic Cancer

NCT05202314

Conditions: Bites and Stings, Chemically-Induced Disorders, Colonic Diseases, +17 more
Locations: Beijing Chaoyang Hospital, Capital Medical University Beijing, Beijing Municipality, China

View Trial Details

Recruiting

Molecular Monitoring of cfDNA by ddPCR in Non-small Cell Lung Cancer Treated by Immunotherapy.

NCT04720339

Conditions: Immunotherapy, NSCLC, QUANTIFICATION OF CELL-FREE DNA
Locations: CHU de Besancon - Service de pneumologie Besançon, France

Hopitaux Civils de Colmar - service de Pneumologie Colmar, France

CHU de Dijon - service de Pneumologie Dijon, France

CLCC Georges-François Leclerc Dijon, France

View Trial Details

Recruiting

Ajuvant Chemotherapy and Immunotherapy in Patients With Esophageal, Esophageal- Gastric Junction Cancer

NCT04688801

Conditions: Adjuvant, Digestive System Diseases, Digestive System Neoplasms, +10 more
Locations: The Second Hospital of Shandong University Jinan, Shandong, China

View Trial Details

Recruiting

A Exploratory Study of Vγ2Vδ2 T Lymphocyte-based Immunotherapy for MDR-TB

NCT05493267

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +7 more
Locations: Shanghai Pulmonary Hospital, Shanghai, China Shanghai, China

Shanghai Pulmonary Hospital Shanghai, China

View Trial Details

Immunotherapy

Immunotherapy trial results

Related conditions